Niagen Bioscience
NAGE
155 hedge funds and large institutions have $418M invested in Niagen Bioscience in 2025 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 74 increasing their positions, 25 reducing their positions, and 21 closing their positions.
196% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 25
143% more capital invested
Capital invested by funds: $172M → $418M (+$246M)
81% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 21
12% more funds holding
Funds holding: 139 → 155 (+16)
10% more call options, than puts
Call options by funds: $3.47M | Put options by funds: $3.14M
4.82% more ownership
Funds ownership: 32.02% → 36.84% (+4.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nuveen
Charlotte,
North Carolina
|
+$8.29M |
| 2 |
WCM
Woodson Capital Management
Greenwich,
Connecticut
|
+$4.94M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.79M |
| 5 |
Morgan Stanley
New York
|
+$3.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$4.73M |
| 2 |
IC
Iconiq Capital
San Francisco,
California
|
-$4.04M |
| 3 |
TCM
Tieton Capital Management
Yakima,
Washington
|
-$4M |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$2.1M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.35M |
NAGE Hedge Fund Activity: Q2 2025 in Review
155 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q2 2025, worth a combined $418M — up 143% from $172M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new NAGE positions and 21 closed out — a net gain of 17 holders — while 74 added to existing stakes and 25 trimmed.
The largest buyer was Nuveen, adding an estimated $8.29M. The largest seller was Millennium Management, cutting an estimated $4.73M.
- 155 institutional investors held Niagen Bioscience (NAGE) as of Q2 2025, up from 139 in Q1 2025.
- Funds reported $418M of Niagen Bioscience stock for Q2 2025, up 143% quarter-over-quarter.
- 38 funds opened new Niagen Bioscience positions in Q2 2025 and 21 closed out, a net change of +17 holders.
- The largest Niagen Bioscience buyer in Q2 2025 was Nuveen, an estimated $8.29M added.
- The largest Niagen Bioscience seller in Q2 2025 was Millennium Management, an estimated $4.73M sold.
Based on aggregated 13F filings for Q2 2025.